Mylan wins in patent battle over combo arthritis drug

A generic version of an anti-inflammatory combination drug used for those with various forms of arthritis will now be made available for the first time in Canada and in fact the world, and for less.Considered a major win in Federal Court, last week lawyers for Mylan Pharmaceuticals emerged the...